Literature DB >> 10515405

Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness.

Y Y Koh1, J H Jeong, Y Park, C K Kim.   

Abstract

Two theories explaining the mechanism for the manifestation of cough without wheeze in patients with cough variant asthma (CVA) are either a higher wheezing threshold or a milder degree of airway hyperresponsiveness. A significant proportion of patients diagnosed as having CVA eventually develop wheezing. The aim of this study was to investigate whether this change in the manifestation of asthma was associated with a decrease in wheezing threshold and/or an increase in airway hyperresponsiveness. Thirty-six children (7-15 yrs) with CVA were prospectively studied for 4 yrs. Bronchial provocation tests with methacholine using the stepwise increasing concentration technique were performed annually to measure the provocative cumulative dose producing a 20% fall in forced expiratory volume in one second (PD20). Wheezing thresholds were additionally determined at the initiation of and the end of the study (development of wheezing, or after 4 yrs). Sixteen (Group 1) of 29 patients available for the follow-up developed clinical wheezing during the period; 13 patients (Group 2) stayed as CVA or their cough resolved. There was no significant change in wheezing thresholds from the initiation to the end of the study (Group 1: 40.9+/-8.2% versus 40.2+/-8.3%; Group 2: 41.4+/-7.1% versus 40.1+/-7.3%). Methacholine PD20 (geometric mean, range of 1 SD), expressed as breath unit (BU), significantly decreased in Group 1 patients as they developed wheezing (initial versus wheezing year: 60.8 BU, 29.2-126.5 versus 32.8 BU, 11.5-93.3; p<0.01), whereas the value did not change in Group 2 patients (initial versus after 4 yrs: 85.3 BU, 45.2-161.1 versus 84.3 BU, 39.7-179.1; NS). The results suggest that an increase in airway hyperresponsiveness, but not a decrease in wheezing threshold, may have a pathogenetic role in the development of wheezing during the course of cough variant asthma in childhood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515405     DOI: 10.1034/j.1399-3003.1999.14b11.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Diagnostic Value of Fractional Exhaled Nitric Oxide and Small Airway Function in Differentiating Cough-Variant Asthma from Typical Asthma.

Authors:  Yanqi Wang; Lixuan Zhao; Fang Chen; Yufeng Guo; Hongxia Ma; Baofen Han; Jiang Yi; Xiaomei Kong
Journal:  Can Respir J       Date:  2021-08-20       Impact factor: 2.409

Review 3.  The current state of cough research: the clinician's perspective.

Authors:  Louis-Philippe Boulet
Journal:  Lung       Date:  2007-10-03       Impact factor: 2.584

4.  Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of HuangQiXiXin Decoction on Cough Variant Asthma and Evidence-Based Medicine Approach Validation.

Authors:  Qingqing Xia; Mingtao Liu; Hui Li; Lijun Tian; Jia Qi; Yufeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-30       Impact factor: 2.629

Review 5.  WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation - Updates in COVID-19.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona S Al-Ahmad; Anahi Yañez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; René Maximiliano Gómez; Sandra N Gonzalez Diaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana K Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; Jose Antonio Ortega-Martell; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2021-11-22       Impact factor: 4.084

6.  Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross-sectional study.

Authors:  Hisako Matsumoto; Akio Niimi; Masaya Takemura; Tetsuya Ueda; Masafumi Yamaguchi; Hirofumi Matsuoka; Makiko Jinnai; Kazuo Chin; Michiaki Mishima
Journal:  Cough       Date:  2009-03-09

7.  A retrospective study of clinical features of cough variant asthma in Chinese adults.

Authors:  Weiping Liu; Huaping Chen; Dehua Zhang; Feng Wu; Liqin Zhou
Journal:  Allergy Asthma Clin Immunol       Date:  2019-01-17       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.